Zota Health Care LImited
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America.
What Zota files
- Others83
- Investor Meet32
- Updates30
- QIP/Rights/Pref.22
- Important16
- Board Meeting16
Zota Health Care acquired an 80% stake in Globotask IT Consultancy Services for Rs 0.25 Cr. This acquisition aims to integrate IT solutions, including cloud, app, and ERP development, for Zota and its subsidiaries.
Zota Health Care's Promoter Directors have voluntarily capped their cumulative annual remuneration at 12 Cr until FY2030. This move aims for enhanced corporate governance and improved capital allocation for company growth.
Zota Health Care seeks to raise its internal limit for loans/investments from 500 Cr to 1,000 Cr via postal ballot. This expanded headroom supports strategic acquisitions, new investments, and critical working capital for its revenue-driving Davaindia subsidiary, as the previous limit is exhausted.
Zota Health Care (ZOTA) signed an MOU to acquire 100% stake in Curexis Ventures by buying 1,00,000 shares. This acquisition expands ZOTA's footprint in the retail generic pharmacy chain segment, bolstering future growth.
Zota Health Care's Fund Raising Committee has successfully closed its Qualified Institutional Placement (QIP). The company will allot 22,80,130 equity shares to qualified institutional buyers at ₹1,535 per share. This issue price includes a premium of ₹1,525 per share and was finalized with a discount of ₹80.28 per share from...